Ho, Shu-Yi <br/><br/>
Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules.  [electronic resource] 

 -  Journal of nanobiotechnology  Apr 2020 
 - 58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-3155 
<br/><br/><label>Standard No.: </label>10.1186/s12951-020-00610-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Angiogenesis Inhibitors--genetics<br/>Animals<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Genetic Therapy--methods<br/>Immunoglobulin Fc Fragments--genetics<br/>Liposomes--chemistry<br/>Male<br/>Melanoma, Experimental--mortality<br/>Mice<br/>Mice, Inbred C57BL<br/>Plasmids--chemistry<br/>Protein Domains--genetics<br/>Receptors, Vascular Endothelial Growth Factor--genetics<br/>Recombinant Fusion Proteins--biosynthesis<br/>Survival Rate<br/>Transplantation, Homologous<br/>Vascular Endothelial Growth Factor A--genetics